Navigation Links
Johns Hopkins experts to present genetics advances at international meeting this weekend
Date:4/12/2013

Johns Hopkins genetics researchers Aravinda Chakravarti, Ph.D., and David Valle, M.D., will each present at the joint conference of the Human Genome Meeting 2013 and the 21st International Congress of Genetics. The conference, which will take place in Singapore April 13-18, 2013, will focus on the genetics and genomics of world health and sustainability. Chakravarti and Valle are the former and current director, respectively, of the Johns Hopkins University McKusick-Nathans Institute of Genetic Medicine.

Both Chakravarti and Valle will speak at the conference's "Mendelian Genetic Diseases" session, to be held on April 13 from 10 a.m. to 12 p.m. local time. Chakravarti will relate his findings about Hirschsprung's disease, an inherited intestinal disorder that, he has found, can be caused by a number of different rare genetic variations. Valle will speak about the work of the Baylor-Johns Hopkins Center for Mendelian Genetics, a four-year, National Institutes of Health-funded search for the culprits behind single-gene diseases usually called Mendelian disorders.

On April 18 at 8:30 a.m., Chakravarti will chair a plenary discussion in which he will reflect on progress in genomics since the sequencing of the human genome 10 years ago, focusing on the areas of ethical issues, identifying disease genes and understanding gene mechanisms. Related stories:

Chakravarti:

Genome-Wide Hunts Reveal New Regulators of Blood Pressure: http://www.hopkinsmedicine.org/news/media/releases/genome_wide_hunts_reveal_new_regulators_of_blood_pressure

The 1,000 Genomes Project: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2010_12/2010_12_1000_genomes.html

Teasing Apart the Genetics of a Complex Disorder: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2010_09/2010_09_Aravinda.html

New Genes Implicated in High Blood Pressure: http://www.hopkinsmedicine.org/news/media/releases/New_Genes_Implicated_in_High_Blood_Pressure

Big Man in Genes: http://www.hopkinsmedicine.org/hmn/W02/top.html

Valle:

Individualized Medicine Comes to Johns Hopkins: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2009_03/2009_03_feature.html

Johns Hopkins Researchers Discover New Schizophrenia Gene: http://m.hopkinsmedicine.org/news/media/releases/Johns_Hopkins_Researchers_Discover_New_Schizophrenia_Gene

The Johns Hopkins Center for Inherited Disease Research Receives $101 Million: http://m.hopkinsmedicine.org/news/media/releases/the_johns_hopkins_center_for_inherited_disease_research_receives_101_million

New Database to Speed Genetic Discoveries: http://www.hopkinsmedicine.org/news/media/releases/new_database_to_speed_genetic_discoveries


'/>"/>

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
2. Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
3. Sun Yat-sen University and Johns Hopkins sign collaboration agreement
4. US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke Or Heart Attack After Using Birth Control Pills Call Yaz, Or Yasmin to Call the Johnson Law Group
5. US Drug Watchdog Now Urges Families Of Diabetics Who Developed Bladder Cancer After Using The Diabetes Drug Called To Call The Johnson Law Group-For A Legal Review
6. Los Angeles Personal Injury Attorney Jeff Nadrich Responds to News that Johnson & Johnson Inadequately Assessed Metal Hip Dangers
7. Johns Hopkins Medicine expands reach in Latin America
8. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke As Far Back As 2005 to Call The Johnson Law Group-Nationwide
9. US Drug Watchdog Now Urges All Diabetics Nationwide Who Used the Diabetes Drug Actos and now have Bladder Cancer to Call The Johnson Law Group For A Legal Evaluation
10. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke in 2008, or 2009 to Call The Johnson Law Group-Before Time Runs Out
11. US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos and Then Developed Bladder Cancer to Call the Johnson Law Group for a Legal Review - Get Compensated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Aerolib Healthcare Solutions ... Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization Review ... of Disease Specific Documentation Improvement. , The Aerolib Learning Management System is ...
(Date:1/19/2017)... ... 19, 2017 , ... LabRoots , the leading provider ... world, announces the launch of its newly redesigned website. The sleek new design ... and trending news, vital information on upcoming virtual events and webinars, all while ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Gattefossé, the leader in innovative excipients and drug delivery solutions to health industries ...
(Date:1/19/2017)... ... ... Students interested in video can get a jump start on their education ... $1,000 scholarship and have his or her video posted on the GenCure website and ... with the winner announced on June 9. , The competition is designed to help ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Sam & Associates ... to commercial and residential clients in the California Bay Area, is launching a charity ... in the region. , Heart disease is the primary killer of adult men and ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... 18, 2017   Synthetic Biologics, Inc. ... therapeutics designed to preserve the microbiome to protect ... plans to initiate a Phase 2b/3 adaptive pivotal ... lovastatin lactone designed to reduce methane production by ... gut to treat the underlying cause of irritable ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
Breaking Medicine Technology: